Herborium Group, Inc.
HBRM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.09M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.09 Million |
|---|---|
| Enterprise Value | $2.16 Million |
| Earnings per Share | $0 |
| Beta | 7.41 |
| Outstanding Shares | 10,919,428,835 |
Return
| Return on Equity | 5.58% |
|---|---|
| Return on Assets | -319.37% |
| Return on Invested Capital | 13.80% |
Valuation & Multiples
| P/E Ratio | -4.55 |
|---|---|
| PEG | -4.45 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 2.66 |
| Enterprise Value to EBIT | -7.2 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | -0.25 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Herborium Group, Inc.
2 employees
CEO: Agnes Olszewski
Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals...